Details of the Drug | DrugMAP

General Information of Drug (ID: DM4S5UO)

Drug Name

NDV-3A

Indication

Disease Entry	ICD 11	Status	REF
Staphylococcus infection	1B5Y	Phase 2	[1]
Vulvovaginal Candidiasis	1F23.10	Phase 2	[2]
Candidiasis	1F23	Phase 1/2	[3]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

TTD ID: D9DS8O

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT03455309) Evaluation of NDV-3A Vaccine in Preventing S. Aureus Colonization. U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT01926028) Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis. U.S. National Institutes of Health.
3	ClinicalTrials.gov (NCT01926028) Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis. U.S. National Institutes of Health.